Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
Jemy A. Gutierrez, Wei Liu, Sylvie Perez, et al.
Molecular Metabolism (2021) Vol. 48, pp. 101196-101196
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman, Morris J. Birnbaum
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2329-2354
Open Access | Times Cited: 192
Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia
Marisa R. Morrow, Battsetseg Batchuluun, Jianhan Wu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 919-936.e8
Open Access | Times Cited: 111
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Mark A. Febbraio, Michael Karin
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2316-2328
Open Access | Times Cited: 104
The role of ChREBP in carbohydrate sensing and NAFLD development
Marion Régnier, Thaïs Carbinatti, Lucia Parlati, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 6, pp. 336-349
Closed Access | Times Cited: 47
Pharmacologic inhibition of lipogenesis for the treatment of NAFLD
William P. Esler, David E. Cohen
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 362-377
Open Access | Times Cited: 41
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
Mustafa Kutlu Inci, Sehyung Park, Robert N. Helsley, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109224-109224
Open Access | Times Cited: 39
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Gideon G. Kang, Natalie L. Trevaskis, Andrew Murphy, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105905-105905
Open Access | Times Cited: 38
Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation
Robert N. Helsley, Sehyung Park, Hemendra J. Vekaria, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 25-42
Open Access | Times Cited: 28
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
Guocheng Rao, Xi Peng, Xinqiong Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 22
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
Tilal Elsaman, Magdi Awadalla Mohamed
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
In Silico Analysis of Saroglitazar and Ferulic Acid Binding to Human Ketohexokinase: Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Kalpana Tiwari, Brijesh Kumar, Anurag Tiwari, et al.
Cureus (2025)
Open Access | Times Cited: 1
Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms
Gregory R. Steinberg, Celina M. Valvano, William De Nardo, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 1
The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
Siyu Yu, Chunlin Li, Guang Ji, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Algera Goga, Markus Stoffel
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 417-439
Closed Access | Times Cited: 34
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 6
Metabolomics analysis reveals novel serum metabolite alterations in cancer cachexia
Tushar H. More, Karsten Hiller, Martin Seifert, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease
Mareca Lodge, Rachel Dykes, Arion Kennedy
Biomolecules (2024) Vol. 14, Iss. 7, pp. 845-845
Open Access | Times Cited: 6
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Metabolism (2022) Vol. 134, pp. 155264-155264
Closed Access | Times Cited: 24
Hepatic fructose metabolism is antagonized by growth hormone/insulin-like growth factor signaling via regulation of ketohexokinase expression
Salaheldeen Elsaid, Prathibha Meesala, Youngshim Choi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Litiasis úrica
A. Pruna, M. Daudon
EMC - Urología (2025) Vol. 57, Iss. 1, pp. 1-22
Closed Access
Pharmacophore-based virtual screening and in silico investigations of small molecule library for discovery of human hepatic ketohexokinase inhibitors for the treatment of fructose metabolic disorders
Tilal Elsaman, Magdi Awadalla Mohamed, Abozer Y. Elderdery, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
High dietary Fructose Drives Metabolic Dysfunction-Associated Steatotic Liver Disease via Activating ubiquitin-specific peptidase 2/11β-hydroxysteroid dehydrogenase type 1 Pathway in Mice
Chunlin Li, Meng Li, Sheng Wei, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3480-3496
Open Access | Times Cited: 4
Repercussions of the Maternal Obesogenic Diet on the Oxidative Balance and Pancreatic Metabolism in Male Juvenile Offspring
Wellington de Almeida Oliveira, Gizele Santiago de Moura Silva, Ramon Nascimento da Silva, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 578-578
Open Access
Page 1 - Next Page

Scroll to top